Source: Hormone research in paediatrics. Conference titles: 51th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE). Unidade: FM
Subjects: PUBERDADE PRECOSE, TESTOSTERONA (NÍVEL), NEUROENDORCRINOLOGIA, HORMÔNOS (USO TERAPÊUTICO), RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRITO, Vinicius Nahime et al. Effectiveness of leuprolide acetate 3-month depot (11.25 mg) in the treatment of patients with central precocious puberty: experience of. Hormone research in paediatrics. Basel: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1159/000343184. Acesso em: 05 nov. 2024. , 2012APA
Brito, V. N., Cukier, P., Lima, L. O., Silveira, L. F. G., Teles, M., Mendonça, B. B., et al. (2012). Effectiveness of leuprolide acetate 3-month depot (11.25 mg) in the treatment of patients with central precocious puberty: experience of. Hormone research in paediatrics. Basel: Faculdade de Medicina, Universidade de São Paulo. doi:10.1159/000343184NLM
Brito VN, Cukier P, Lima LO, Silveira LFG, Teles M, Mendonça BB, Arnhold IJP, Latronico AC. Effectiveness of leuprolide acetate 3-month depot (11.25 mg) in the treatment of patients with central precocious puberty: experience of [Internet]. Hormone research in paediatrics. 2012 ;78( suppl. 1): 232.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1159/000343184Vancouver
Brito VN, Cukier P, Lima LO, Silveira LFG, Teles M, Mendonça BB, Arnhold IJP, Latronico AC. Effectiveness of leuprolide acetate 3-month depot (11.25 mg) in the treatment of patients with central precocious puberty: experience of [Internet]. Hormone research in paediatrics. 2012 ;78( suppl. 1): 232.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1159/000343184
